Valuation : Aprogen Biologics Inc.

Market Cap 24.07B 17.96M 15.47M 14.65M 13.28M 24.91M 1.72B 25.04M 174M 66.91M 873M 67.44M 65.96M 2.76B P/E 2024
-0.79x
P/E 2025 -0.6x
Enterprise Value 201B 150M 129M 122M 111M 208M 14.34B 209M 1.45B 559M 7.3B 564M 551M 23.06B EV / Sales 2024
3.66x
EV / Sales 2025 3.82x
Free-Float
42.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
1 week-7.24%
Current month-6.72%
1 month-21.17%
3 months-34.80%
6 months-60.02%
Current year-78.43%
1 week 1,616
Extreme 1616
1,940
1 month 1,616
Extreme 1616
2,455
Current year 1,616
Extreme 1616
8,490
1 year 1,616
Extreme 1616
9,945
3 years 1,616
Extreme 1616
67,500
5 years 1,616
Extreme 1616
204,750
10 years 1,616
Extreme 1616
858,000
Manager TitleAgeSince
Chief Executive Officer 63 12/10/2023
Chief Executive Officer 70 31/03/2012
Sales & Marketing 62 -
Director TitleAgeSince
Director/Board Member 70 31/03/2012
Director/Board Member 65 22/03/2020
Director/Board Member 63 12/10/2023
Date Insider Type Main position Quantity % Market Cap. Importance
28/06/24 Exercice

Executive/Senior Manager

6,183 0.0046%
28/06/24 Expiration

Chief Executive Officer

21,884 0.0164%
28/06/24 Exercice 11,846 0.0089% -
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-7.24%-82.86%-97.36% 17.96M
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-0.73%+9.58% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.63%-59.44% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.61%-5.95%+11.59%+26.58% 350.48B
Weighted average by Cap. -0.51%-4.42%+30.96%+54.95%

Financials

2024 2025
Net sales 67.38B 50.27M 43.31M 41.01M 37.17M 69.73M 4.8B 70.08M 487M 187M 2.44B 189M 185M 7.72B 73.23B 54.63M 47.07M 44.57M 40.4M 75.78M 5.22B 76.17M 529M 204M 2.66B 205M 201M 8.39B
Net income -105B -78.32M -67.48M -63.89M -57.91M -109M -7.48B -109M -759M -292M -3.81B -294M -288M -12.03B -170B -127M -109M -104M -93.96M -176M -12.14B -177M -1.23B -473M -6.18B -477M -467M -19.52B
Net Debt 116B 86.31M 74.37M 70.42M 63.83M 120M 8.25B 120M 836M 322M 4.2B 324M 317M 13.26B 177B 132M 114M 108M 97.73M 183M 12.63B 184M 1.28B 492M 6.42B 496M 485M 20.3B
Logo Aprogen Biologics Inc.
Aprogen Biologics Inc, formerly Aprogen Pharmaceuticals Inc, is a Korea-based company principally engaged in the pharmaceutical business. The Company operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
Employees
262
Date Price Change Volume
11/09/26 ₩1,679.00 +0.48% 159,294
10/09/26 ₩1,671.00 +0.84% 173,795
09/09/26 ₩1,657.00 -2.87% 254,324
08/09/26 ₩1,706.00 -6.16% 468,312
07/09/26 ₩1,818.00 +0.44% 787,223
  1. Stock Market
  2. Stocks
  3. A003060 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!